Minesapride

CAS No. 1184662-54-1

Minesapride( —— )

Catalog No. M34335 CAS No. 1184662-54-1

Minesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 283 In Stock
5MG 245 In Stock
10MG 363 In Stock
25MG 562 In Stock
50MG 786 In Stock
100MG 1088 In Stock
200MG 1460 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Minesapride
  • Note
    Research use only, not for human use.
  • Brief Description
    Minesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.
  • Description
    Minesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1184662-54-1
  • Formula Weight
    454.95
  • Molecular Formula
    C21H31ClN4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC[C@H]1CN(CC2CCN(C(CO)=O)CC2)CCO1)(=O)C3=C(OC)C=C(N)C(Cl)=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tedatioxetine hydrob...

    Tedatioxetine hydrobromide (Lu AA 24530 hydrobromide) is a serotonin-norepinephrine-dopamine reuptake inhibitor and an antagonist of 5-HT2A, 5-HT2C, 5-HT3, and α1A-adrenergic receptors, which can be used to treat depression and anxiety.

  • WAY-607695

    WAY-607695 is a potential 5-HT1A receptor agonist.

  • Tabernanthalog

    Tabernanthalog (TBG) is a 5-HT2A agonist. In rodents,Tabernanthalog has been found to promote structural neuroplasticity, reduce alcohol-seeking and heroin-seeking behavior, and produce antidepressant effects.